WORLDWIDE POST-MARKETING SAFETY SURVEILLANCE EXPERIENCE WITH TOFACITINIB IN ULCERATIVE COLITIS

被引：0
|
作者：
Rubin, David T.
Modesto, Irene
Vermeire, Severine
Danese, Silvio
Ng, Siew C.
Kwok, Kenneth K.
Koram, Nana
Jones, Thomas V.
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
130
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [1] Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis
    Rubin, David T.
    Modesto, Irene
    Vermeire, Severine
    Danese, Silvio
    Ng, Siew C.
    Kwok, Kenneth K.
    Koram, Nana
    Jones, Thomas, V
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (03) : 302 - 310
  • [2] Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
    Yoon, Hyuk
    Ye, Byong Duk
    Kang, Sang-Bum
    Lee, Kang-Moon
    Choi, Chang Hwan
    Jo, Joo-young
    Woo, Juwon
    Cheon, Jae Hee
    [J]. BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [3] 18-Month Worldwide Post-Marketing Surveillance Experience of Tofacitinib
    Cohen, S.
    Curtis, J. R.
    Fleischmann, Roy
    Chen, Y.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S199 - S200
  • [4] Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: A final report of effectiveness and safety data
    Matsuoka, K.
    Motoya, S.
    Yamamoto, T.
    Matsuura, M.
    Fujii, T.
    Shinzaki, S.
    Mikami, Y.
    Arai, S.
    Oshima, J.
    Endo, Y.
    Yuasa, H.
    Hoshi, M.
    Sato, K.
    Hisamatsu, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1407 - I1409
  • [5] Editorial: tofacitinib post-marketing safety reports among ulcerative colitis patients
    Veisman, Ido
    Ben-Horin, Shomron
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (01) : 131 - 132
  • [6] Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
    Stanley Cohen
    Jeffrey R. Curtis
    Ryan DeMasi
    Yan Chen
    Haiyun Fan
    Arif Soonasra
    Roy Fleischmann
    [J]. Rheumatology and Therapy, 2018, 5 : 283 - 291
  • [7] Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
    Cohen, Stanley
    Curtis, Jeffrey R.
    DeMasi, Ryan
    Chen, Yan
    Fan, Haiyun
    Soonasra, Arif
    Fleischmann, Roy
    [J]. RHEUMATOLOGY AND THERAPY, 2018, 5 (01) : 283 - 291
  • [8] Safety of opicapone after 5 years of post-marketing experience worldwide
    Guedes, L.
    Graca, J.
    Sampaio, M.
    Vieira, M.
    Rocha, F.
    Gama, H.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S448 - S449
  • [9] Safety of opicapone after 5 years of post-marketing experience worldwide
    Guedes, Luis
    Graca, Joana
    Sampaio, Maria
    Vieira, Mariana
    Rocha, Francisco
    Gama, Helena
    [J]. NEUROLOGY, 2023, 100 (17)
  • [10] Post-marketing device safety surveillance
    Vidi, Venkatesan D.
    Matheny, Michael E.
    Resnic, Frederic S.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2011, 32 (03) : 307 - 308
12345